Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in skeletal muscle. J. Cell. Mol. Med. 16, 752-64


Authors

Cabello-Verrugio, C., Morales, G, Cabrera, D and Brandan, E. (2012)

Lab(s)


Comparte: